171 related articles for article (PubMed ID: 10927025)
1. Allosteric modulation of A(2A) adenosine receptors by amiloride analogues and sodium ions.
Gao ZG; Ijzerman AP
Biochem Pharmacol; 2000 Sep; 60(5):669-76. PubMed ID: 10927025
[TBL] [Abstract][Full Text] [Related]
2. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation.
Gao ZG; Jiang Q; Jacobson KA; Ijzerman AP
Biochem Pharmacol; 2000 Sep; 60(5):661-8. PubMed ID: 10927024
[TBL] [Abstract][Full Text] [Related]
4. A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
Mazzoni MR; Taddei S; Giusti L; Rovero P; Galoppini C; D'Ursi A; Albrizio S; Triolo A; Novellino E; Greco G; Lucacchini A; Hamm HE
Mol Pharmacol; 2000 Jul; 58(1):226-36. PubMed ID: 10860945
[TBL] [Abstract][Full Text] [Related]
5. 5'-Substituted Amiloride Derivatives as Allosteric Modulators Binding in the Sodium Ion Pocket of the Adenosine A2A Receptor.
Massink A; Louvel J; Adlere I; van Veen C; Huisman BJ; Dijksteel GS; Guo D; Lenselink EB; Buckley BJ; Matthews H; Ranson M; Kelso M; IJzerman AP
J Med Chem; 2016 May; 59(10):4769-77. PubMed ID: 27124340
[TBL] [Abstract][Full Text] [Related]
6. [(3)H]ZM241385--an antagonist radioligand for adenosine A(2A) receptors in rat brain.
Alexander SP; Millns PJ
Eur J Pharmacol; 2001 Jan; 411(3):205-10. PubMed ID: 11164377
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
Fredholm BB; Lindström K
Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
[TBL] [Abstract][Full Text] [Related]
8. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
Sperlágh B; Zsilla G; Baranyi M; Illes P; Vizi ES
Neuroscience; 2007 Oct; 149(1):99-111. PubMed ID: 17850981
[TBL] [Abstract][Full Text] [Related]
9. Validation of a Na
Noël F; do Monte FM
J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells.
Rego AC; Agostinho P; Melo J; Cunha RA; Oliveira CR
Exp Eye Res; 2000 May; 70(5):577-87. PubMed ID: 10870516
[TBL] [Abstract][Full Text] [Related]
11. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
Palmer TM; Poucher SM; Jacobson KA; Stiles GL
Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012
[TBL] [Abstract][Full Text] [Related]
12. Regulation of D2 dopamine receptors by amiloride and amiloride analogs.
Hoare SR; Strange PG
Mol Pharmacol; 1996 Nov; 50(5):1295-308. PubMed ID: 8913361
[TBL] [Abstract][Full Text] [Related]
13. Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor.
Gao ZG; Kim SK; Gross AS; Chen A; Blaustein JB; Jacobson KA
Mol Pharmacol; 2003 May; 63(5):1021-31. PubMed ID: 12695530
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A
Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315
[TBL] [Abstract][Full Text] [Related]
15. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
16. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain.
Kull B; Svenningsson P; Hall H; Fredholm BB
Neuropharmacology; 2000 Sep; 39(12):2374-80. PubMed ID: 10974321
[TBL] [Abstract][Full Text] [Related]
17. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
Heitman LH; Ye K; Oosterom J; Ijzerman AP
Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
[TBL] [Abstract][Full Text] [Related]
18. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
Tebano MT; Domenici MR; Popoli P
Eur J Pharmacol; 2002 Aug; 450(3):253-7. PubMed ID: 12208317
[TBL] [Abstract][Full Text] [Related]
19. Agonist binding and function at the human alpha(2A)-adrenoceptor: allosteric modulation by amilorides.
Leppik RA; Birdsall NJ
Mol Pharmacol; 2000 Nov; 58(5):1091-9. PubMed ID: 11040058
[TBL] [Abstract][Full Text] [Related]
20. Allosteric interactions between the antagonist prazosin and amiloride analogs at the human alpha(1A)-adrenergic receptor.
Leppik RA; Mynett A; Lazareno S; Birdsall NJ
Mol Pharmacol; 2000 Mar; 57(3):436-45. PubMed ID: 10692482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
